President’s Letter | April 2024
…approval in February of Amtagvi (lifileucel), the TILs therapy for the treatment of metastatic melanoma (read about all FDA approved…















Copyright © 2014-2022 - AIM at Melanoma Foundation. All rights reserved. Website by RED ZEPHYR DESIGN